Furtado JM, Jonas JB, Tapply I, Fernandes AG, Cicinelli MV, Arrigo A, Leveziel N, Resnikoff S, Taylor HR, Sedighi T, Flaxman S, Battaglia Parodi M, Bikbov MM, Braithwaite T, Bron A, Cheng CY, Congdon N, Del Monte MA, Ehrlich JR, Fricke T, Friedman D, Gazzard G, Hartnett ME, Kahloun R, Kempen JH, Khairallah M, Khanna RC, Kim JE, Lansingh VC, Leasher J, Naidoo KS, Nangia V, Nowak M, Pesudovs K, Peto T, Ramulu P, Topouzis F, Tsilimbaris M, Wang YX, Wang N, Bourne RRA, Furtado JM, Jonas JB, Fernandes AG, Cicinelli MV, Leveziel N, Briant PS, Vos T, Resnikoff S, Fischer F, Abate YH, Abdollahi M, Adal TGG, Addo IY, Adhikari K, Agarwal P, Agodi A, Agyemang-Duah W, Ahmad A, Ahmadieh H, Ahmadzadeh H, Alahdab F, Alfaar AS, Alhassan RK, Ali SSS, Almidani L, Androudi S, Anil A, Anyasodor AE, Arabloo J, Ashemo MY, Athari SS, Atnafu DD, Atreya A, Ayalew MK, Aynalem YA, Aynalem ZB, Azzam AY, Bagherieh S, Bai R, Barchitta M, Bardhan M, Bärnighausen TW, Bayileyegn NS, Bazvand F, Begde A, Behnam B, Bhagavathula AS, Bhaskar S, Bhatti GK, Bhatti JS, Bintoro BS, Birck MG, Braithwaite T, Burkart K, Bustanji Y, Caetano dos Santos FL, Carneiro VLA, Cenderadewi M, Chattu VK, Chu DT, Coberly K, Cruz-Martins N, Dadras O, Dai X, Dascalu AM, Dashti M, Dastiridou A, Dastmardi M, Deng X, Dervenis N, Devanbu VGC, Diress M, Djalalinia S, Ehrlich JR, Ekholuenetale M, Ekundayo TC, El Sayed I, Elhadi M, Emamverdi M, Emrie AA, Fagbamigbe AF, Fahim A, Farooq U, Farrokhpour H, Fatehizadeh A, Feizkhah A, Ferro Desideri L, Fetensa G, Feyisa BR, Flaxman S, Forouhari A, Foschi M, Fowobaje KR, Gandhi AP, Gebi TG, Gebregergis MW, Gebrehiwot M, Gebremariam B, Gebremeskel GG, Gela YY, Gesese MM, Ghasemi Falavarjani K, Ghassemi F, Ghozy S, Golechha M, Goleij P, Gupta S, Gupta VB, Gupta VK, Haile TG, Hailu SG, Haj-Mirzaian A, Halimi A, Hallaj S, Hammond BR, Hasan I, Hasani H, Hassanian-Moghaddam H, Heidari-Foroozan M, Hong SH, Hoogar P, Hosseinzadeh M, Hu C, Huynh HH, Immurana M, Iwu CCD, Jacob L, Jafarzadeh A, Jakovljevic M, Jayaram S, Jokar M, Joseph N, Joshua CE, Kabito GG, Kalankesh LR, Kamath S, Kandel H, Karaye IM, Kasraei H, Kayode GA, Kedir S, Khader YS, Khajuria H, Khatatbeh MM, Khatib MN, Khorrami Z, Kim YJ, Kisa A, Kisa S, Kosen S, Koyanagi A, Krishan K, Lahariya C, Laksono T, Lal DK, Lansingh VC, Le TDT, Leasher JL, Lee M, Lee SW, Lee WC, Lim SS, Liu X, Mahmoudi A, Mahmoudi R, Malhotra K, Mansouri V, Marzo RR, Maugeri A, McAlinden C, Mekene Meto T, Mersha AM, Mestrovic T, Mihretie ET, Mirzaei M, Mithra P, Mohamed NS, Mohammadi S, Mohammed A, Mokdad AH, Molavi Vardanjani H, Moni MA, Montazeri F, Moradi M, Mousavi P, Muhamed AN, Mulita A, Naidoo KS, Naik GR, Nargus S, Natto ZS, Nayak BP, Negaresh M, Negash H, Nejadghaderi SA, Nguyen DH, Nguyen HQ, Nguyen PT, Nguyen VT, Niazi RK, Noreen M, Nzoputam OJ, Odetokun IA, Olagunju AT, Olatubi MI, Onwujekwe OE, Ordak M, Osuagwu UL, Otstavnov N, Owolabi MO, Padubidri JR, Panahi P, Pandey A, Pardhan S, Patel J, Patthipati VS, Pawar S, Perianayagam A, Petcu IR, Pham HT, Qattea I, Raghav PR, Rahim F, Rahimi-Movaghar V, Rahman MHU, Rahman M, Ramasubramani P, Rashid AM, Rauf AU, Redwan EMM, Rezaei N, Roy P, Saadatian Z, Sabour S, Saddik B, Saeed U, Safi S, Safi SZ, Saghazadeh A, Saheb Sharif-Askari F, Saheb Sharif-Askari N, Sahebkar A, Sakshaug JW, Salahi S, Salahi S, Saleh MA, Samodra YL, Samuel VP, Samy AM, Saravanan A, Sawhney M, Saylan M, Sediqi SM, Selvaraj S, Sethi Y, Seylani A, Shah J, Shahid S, Shahwan MJ, Shaikh MA, Shamim MA, Shayan M, Shigematsu M, Shittu A, Shorofi SA, Siddig EE, Silva JC, Singh JA, Singh P, Skiadaresi E, Sousa RARC, Sreeramareddy CT, Starodubov VI, Taye BT, Ticoalu JHV, Tsegay GM, Tsilimbaris MK, Ullah S, Umair M, Valadan Tahbaz S, Wickramasinghe ND, Wondimagegn GS, Yang L, Yiğit A, Yon DK, Yonemoto N, You Y, Zastrozhin MS, Zhao H, Zheng P, Ziafati M, Zielińska M, Steinmetz JD, Bourne RRA. Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020.
Eye (Lond) 2024;
38:2070-2082. [PMID:
38965321 PMCID:
PMC11269688 DOI:
10.1038/s41433-024-03050-z]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Revised: 03/11/2024] [Accepted: 03/26/2024] [Indexed: 07/06/2024] Open
Abstract
BACKGROUND
We aimed to update estimates of global vision loss due to age-related macular degeneration (AMD).
METHODS
We did a systematic review and meta-analysis of population-based surveys of eye diseases from January, 1980, to October, 2018. We fitted hierarchical models to estimate the prevalence of moderate and severe vision impairment (MSVI; presenting visual acuity from <6/18 to 3/60) and blindness ( < 3/60) caused by AMD, stratified by age, region, and year.
RESULTS
In 2020, 1.85 million (95%UI: 1.35 to 2.43 million) people were estimated to be blind due to AMD, and another 6.23 million (95%UI: 5.04 to 7.58) with MSVI globally. High-income countries had the highest number of individuals with AMD-related blindness (0.60 million people; 0.46 to 0.77). The crude prevalence of AMD-related blindness in 2020 (among those aged ≥ 50 years) was 0.10% (0.07 to 0.12) globally, and the region with the highest prevalence of AMD-related blindness was North Africa/Middle East (0.22%; 0.16 to 0.30). Age-standardized prevalence (using the GBD 2019 data) of AMD-related MSVI in people aged ≥ 50 years in 2020 was 0.34% (0.27 to 0.41) globally, and the region with the highest prevalence of AMD-related MSVI was also North Africa/Middle East (0.55%; 0.44 to 0.68). From 2000 to 2020, the estimated crude prevalence of AMD-related blindness decreased globally by 19.29%, while the prevalence of MSVI increased by 10.08%.
CONCLUSIONS
The estimated increase in the number of individuals with AMD-related blindness and MSVI globally urges the creation of novel treatment modalities and the expansion of rehabilitation services.
Collapse